4/A//SEC Filing
Guyer William 4/A
Accession 0001193125-25-307194
CIK 0001088856other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 8:08 PM ET
Size
9.1 KB
Accession
0001193125-25-307194
Insider Transaction Report
Form 4/AAmended
Guyer William
Chief Development Officer
Transactions
- Gift
Common Stock
2025-11-17−5,287→ 0 total - Other
Common Stock
2025-11-17+5,287→ 5,287 total(indirect: By Trust) - Sale
Common Stock
2025-11-25$80.90/sh−4,500$364,070→ 787 total(indirect: By Trust)
Footnotes (5)
- [F1]This transaction was inadvertently omitted from previous filings.
- [F2]Transfer of shares without consideration to The Lake Bainwood Living Trust.
- [F3]Represents the shares held by The Lake Bainwood Living Trust of which the Reporting Person is a co-trustee.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.81 to $81.085 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F5]On November 26, 2025, the Reporting Person filed a Form 4 that inadvertently reported that the 4,500 shares sold were held directly. By this amendment, the Reporting Person corrects such report by reporting that the shares sold were held indirectly by The Lake Bainwood Living Trust of which the Reporting Person is a co-trustee as a result of the transfer that occurred on November 17, 2025, now reported in this amendment.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001879013
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 8:08 PM ET
- Size
- 9.1 KB